Kara M D Hunter (Kara Rainbow)

Publication Activity (10 Years)

Years Active: 2016-2023
Publications (10 Years): 2

Top Topics

Transcription Factor

Squamous Cell Carcinoma

Placebo Controlled

Top Venues

The Journal of clinical endocrinology and metabolism

This page only lists publications with an associated author ORCID identifier.

Publications

Katie Duckett, Alice Williamson, John W R Kincaid, Kara M D Hunter, Laura J Corbin, Hilary C Martin, Ruth Y Eberhardt, Qin Qin Huang, Matthew E Hurles, Wen He, Raja Brauner, Angela Delaney, Leo Dunkel, Romina P Grinspon, Janet E Hall, Joel N Hirschhorn, Sasha R Howard, Ana C Latronico, Alexander A L Jorge, Ken McElreavey, Verónica Mericq, Paulina M Merino, Mark R Palmert, Lacey Plummer, Rodolfo A Rey, Raíssa C Rezende, Stephanie B Seminara, Kathryn Salnikov, Indraneel Banerjee, Brian Yee Hong Lam, John R B Perry, Nicholas John Timpson, Peter Ellis Clayton, Yee-Ming Chan, Ken K Ong, Stephen I O'Rahilly
Prevalence of deleterious variants in MC3R in patients with constitutional delay of growth and puberty. The Journal of clinical endocrinology and metabolism (2023)
John A Todd, Marina Evangelou, Antony J Cutler, Marcin L Pekalski, Neil M Walker, Helen E Stevens, Linsey Porter, Deborah J Smyth, Daniel B Rainbow, Ricardo C Ferreira, Laura Esposito, Kara M D Hunter, Kevin W Loudon, Kathryn Irons, Jennie H Yang, Charles J M Bell, Helen Schuilenburg, James Heywood, Ben Challis, Sankalpa Neupane, Pamela Clarke, Gillian Coleman, Sarah Dawson, Donna Goymer, Katerina Anselmiova, Jane Kennet, Judy Brown, Sarah L Caddy, Martin Turner, Jane Greatorex, Ian Goodfellow, Chris Wallace, Timothy I M Tree, Mark Evans, Adrian P Mander, Simon Bond, Linda S Wicker, Frank Waldron-Lynch
Regulatory T Cell Responses in Participants with Type 1 Diabetes after a Single Dose of Interleukin-2: A Non-Randomised, Open Label, Adaptive Dose-Finding Trial. PLoS medicine 13 (10) (2016)